Bonnie H. Anderson's most recent trade in Bruker Corp was a trade of 4,520 Common Stock done . Disclosure was reported to the exchange on Feb. 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Bruker Corp | Bonnie H. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2026 | 4,520 | 17,847 (0%) | 0% | 0 | Common Stock | |
| Bruker Corp | Bonnie H. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2025 | 3,298 | 13,327 (0%) | 0% | 0 | Common Stock | |
| Bruker Corp | Bonnie Anderson H. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 2,377 | 10,029 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Bonnie H. Anderson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 26.72 per share. | 02 Jun 2023 | 1,304 | 41,377 (0%) | 0% | 26.7 | 34,843 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Apr 2023 | 34,000 | 34,117 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.61 per share. | 14 Apr 2023 | 34,000 | 76,681 (0%) | 0% | 5.6 | 190,740 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director | Sale of securities on an exchange or to another person at price $ 22.04 per share. | 14 Apr 2023 | 34,000 | 42,681 (0%) | 0% | 22.0 | 749,357 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2023 | 34,000 | 68,117 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director | Sale of securities on an exchange or to another person at price $ 22.76 per share. | 15 Mar 2023 | 34,000 | 53,967 (0%) | 0% | 22.8 | 773,888 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.61 per share. | 15 Mar 2023 | 34,000 | 87,967 (0%) | 0% | 5.6 | 190,740 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.10 per share. | 02 Mar 2023 | 8,994 | 53,967 (0%) | 0% | 24.1 | 216,755 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 34,000 | 102,117 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.61 per share. | 17 Jan 2023 | 34,000 | 96,961 (0%) | 0% | 5.6 | 190,740 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director | Sale of securities on an exchange or to another person at price $ 26.30 per share. | 17 Jan 2023 | 29,506 | 67,455 (0%) | 0% | 26.3 | 776,111 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director | Sale of securities on an exchange or to another person at price $ 26.64 per share. | 17 Jan 2023 | 4,494 | 62,961 (0%) | 0% | 26.6 | 119,726 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director | Sale of securities on an exchange or to another person at price $ 25.13 per share. | 11 Jan 2023 | 63,247 | 62,961 (0%) | 0% | 25.1 | 1,589,195 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Jan 2023 | 63,247 | 26,753 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.34 per share. | 11 Jan 2023 | 63,247 | 126,208 (0%) | 0% | 14.3 | 906,962 | Common Stock |
| Bruker Corp | Bonnie H. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 1,970 | 7,652 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.14 per share. | 02 Dec 2022 | 2,042 | 62,961 (0%) | 0% | 29.1 | 59,504 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 50,000 | 90,000 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 14.34 per share. | 01 Dec 2022 | 50,000 | 115,003 (0%) | 0% | 14.3 | 717,000 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Sale of securities on an exchange or to another person at price $ 28.60 per share. | 01 Dec 2022 | 45,460 | 65,003 (0%) | 0% | 28.6 | 1,300,301 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Sale of securities on an exchange or to another person at price $ 27.81 per share. | 01 Dec 2022 | 34,540 | 110,463 (0%) | 0% | 27.8 | 960,447 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.61 per share. | 01 Dec 2022 | 30,000 | 145,003 (0%) | 0% | 5.6 | 168,300 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 30,000 | 136,117 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2022 | 9,244 | 300,756 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.05 per share. | 13 Oct 2022 | 9,244 | 76,091 (0%) | 0% | 9.0 | 83,658 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.86 per share. | 13 Oct 2022 | 1,844 | 66,847 (0%) | 0% | 8.9 | 16,338 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Oct 2022 | 1,844 | 0 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.18 per share. | 02 Sep 2022 | 2,042 | 65,003 (0%) | 0% | 19.2 | 39,166 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Sale of securities on an exchange or to another person at price $ 27.71 per share. | 05 Aug 2022 | 76,917 | 157,426 (0%) | 0% | 27.7 | 2,131,370 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Sale of securities on an exchange or to another person at price $ 27.24 per share. | 05 Aug 2022 | 39,231 | 118,195 (0%) | 0% | 27.2 | 1,068,578 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Sale of securities on an exchange or to another person at price $ 27.82 per share. | 05 Aug 2022 | 5,769 | 112,426 (0%) | 0% | 27.8 | 160,497 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 18.23 per share. | 02 Jun 2022 | 2,042 | 67,045 (0%) | 0% | 18.2 | 37,226 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 20.47 per share. | 01 May 2022 | 736 | 85,952 (0%) | 0% | 20.5 | 15,066 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 32,195 | 32,195 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2022 | 17,667 | 86,688 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.84 per share. | 02 Mar 2022 | 4,521 | 69,021 (0%) | 0% | 27.8 | 125,865 | Common Stock |
| Bruker Corp | Bonnie H. Anderson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2022 | 1,841 | 5,682 (0%) | 0% | 0 | Common Stock | |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Dec 2021 | 11,286 | 1,844 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.86 per share. | 09 Dec 2021 | 11,286 | 73,542 (0%) | 0% | 8.9 | 99,994 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 39.22 per share. | 02 Dec 2021 | 2,288 | 62,256 (0%) | 0% | 39.2 | 89,735 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Sale of securities on an exchange or to another person at price $ 50.18 per share. | 17 Sep 2021 | 2,600 | 217,478 (0%) | 0% | 50.2 | 130,478 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Sale of securities on an exchange or to another person at price $ 50.03 per share. | 10 Sep 2021 | 1,900 | 220,078 (0%) | 0% | 50.0 | 95,050 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 52.97 per share. | 02 Sep 2021 | 2,288 | 64,544 (0%) | 0% | 53.0 | 121,195 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Executive Chairwoman | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.07 per share. | 02 Jun 2021 | 2,288 | 189,725 (0%) | 0% | 36.1 | 82,528 | Common Stock |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 May 2021 | 14,065 | 166,117 | - | - | Stock Option (right to buy) | |
| Veracyte Inc | Bonnie H. Anderson | Director, Chairman and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.61 per share. | 17 May 2021 | 14,065 | 192,013 (0%) | 0% | 5.6 | 78,905 | Common Stock |